AEGR Insider Trading Activity and SEC Form 4 Filings
AEGR insider trading summary
No open-market insider purchases or sales of Aegerion Pharmaceuticals, Inc. (AEGR) have been reported on SEC Form 4 in the past 12 months.
Latest AEGR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 13, 2016 | Kevin Kotler | 10% Owner | Buy | $131K (75,000 @ $1.75) |
| Sep 13, 2016 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Buy | $131K (75,000 @ $1.75) |
| Sep 13, 2016 | Broadfin Capital, LLC | 10% Owner | Buy | $131K (75,000 @ $1.75) |
| Sep 12, 2016 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Buy | $170K (100,000 @ $1.70) |
| Sep 12, 2016 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Buy | $129K (76,000 @ $1.70) |
| Sep 12, 2016 | Kevin Kotler | 10% Owner | Buy | $129K (76,000 @ $1.70) |
| Sep 12, 2016 | Broadfin Capital, LLC | 10% Owner | Buy | $129K (76,000 @ $1.70) |
| Sep 12, 2016 | Kevin Kotler | 10% Owner | Buy | $170K (100,000 @ $1.70) |
| Sep 12, 2016 | Broadfin Capital, LLC | 10% Owner | Buy | $170K (100,000 @ $1.70) |
| Sep 9, 2016 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Buy | $160K (100,000 @ $1.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.